Exclusive
Eucalyptus changes tune and begins selling Ozempic
Nick BonyhadyTechnology writer
Key Points
- Heavily-backed start-up now selling Ozempic, the buzzy weight loss drug.
- Company argues its other medication, Saxenda, is in short supply.
- Government drug regulator says Ozempic is scarce, not Saxenda.
Australia’s biggest weight loss drug selling start-up, Eucalyptus, has begun selling Ozempic after previously insisting it only sold medications specifically approved to help people shed kilograms.
Ozempic has been linked to weight loss by a host of celebrities and influencers but is only recommended in Australia as a treatment for type 2 diabetes.
Loading...
Nick Bonyhady is a technology writer for the Australian Financial Review, based in Sydney. He is a former technology editor, industrial relations and politics reporter at the Sydney Morning Herald and Age. Connect with Nick on Twitter. Email Nick at nick.bonyhady@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Technology
Fetching latest articles